The Safety and Efficacy of the Repeated PRRT with [(90)Y]Y/[(177)Lu]Lu-DOTATATE in Patients with NET

PURPOSE: The peptide receptor radionuclide therapy (PRRT) is a treatment option for patients with disseminated, inoperable G1 and G2 neuroendocrine tumours (NETs). The study aims to evaluate the safety, efficacy, and progression-free survival (PFS) of patients after retreatment (R-PRRT) and re-retre...

Descripción completa

Detalles Bibliográficos
Autores principales: Zemczak, Anna, Gut, Paweł, Pawlak, Dariusz, Kołodziej, Maciej, Królicki, Leszek, Kos-Kudła, Beata, Ruchała, Marek, Kamiński, Grzegorz, Kunikowska, Jolanta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847334/
https://www.ncbi.nlm.nih.gov/pubmed/33552155
http://dx.doi.org/10.1155/2021/6615511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847334/
https://www.ncbi.nlm.nih.gov/pubmed/33552155
http://dx.doi.org/10.1155/2021/6615511

Ejemplares similares